Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001641172-25-004872
Filing Date
2025-04-15
Accepted
2025-04-15 17:15:41
Documents
78

Document Format Files

Seq Description Document Type Size
1 formposam.htm   iXBRL POS AM 2766363
2 ex5-1.htm EX-5.1 9445
3 ex23-1.htm EX-23.1 6344
4 CALCULATION OF REGISTRATION FEE ex107.htm EX-FILING FEES 10904
5 ex5-1_001.jpg GRAPHIC 11065
  Complete submission text file 0001641172-25-004872.txt   9425819

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20241231.xsd EX-101.SCH 65343
7 XBRL CALCULATION FILE otlc-20241231_cal.xml EX-101.CAL 54260
8 XBRL DEFINITION FILE otlc-20241231_def.xml EX-101.DEF 326992
9 XBRL LABEL FILE otlc-20241231_lab.xml EX-101.LAB 454268
10 XBRL PRESENTATION FILE otlc-20241231_pre.xml EX-101.PRE 397070
81 EXTRACTED XBRL INSTANCE DOCUMENT formposam_htm.xml XML 1222963
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-256448 | Film No.: 25840544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)